-
Oral Drug Demonstrates Promising Antitumor Activity in Patients With Advanced Lung Cancer
21 Oct 2025 23:01 GMT
… . This study was funded by Bayer AG. For a full list of …
-
Hospital Infection Therapeutics Market to Reach US$14.7 Billion by 2033 | Astute Analytica
21 Oct 2025 17:15 GMT
… Players:
Actavis plc
AstraZeneca plc
Bayer AG
Bristol-Myers Squibb Company
Cipla …
-
[Latest] Global Aspirin Market Size/Share Worth USD 3.40 Billion by 2034 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
21 Oct 2025 16:30 GMT
… players in the Aspirin Market:
Bayer AG
Suzhou Kuacai Information Technology Co …
-
Banigo Reaffirms Senate’s Commitment To Family Planning Funding As Stakeholders Celebrate TCI Milestones
21 Oct 2025 15:02 GMT
… & Melinda Gates Foundation and Bayer AG for their support and hailed …
-
AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure
21 Oct 2025 12:00 GMT
… operated as a subsidiary of Bayer AG, today announced the publication in … and independently operated subsidiary of Bayer AG, is a fully integrated gene …
-
Top 3 Health Care Stocks You'll Regret Missing In October
21 Oct 2025 12:30 GMT
… (OTC:RHHBY) Tecentriq (atezolizumab) versus Bayer AG's (OTC:BAYRY) Stivarga …
-
Minister of Finance Meets CEOs of Bayer Global, Africa50 to Forge Collaboration
21 Oct 2025 11:04 GMT
… Chief Executive Officer (CEO) of Bayer AG, Bill Anderson and CEO of … Finance and Chief CEO of Bayer AG discussed on potential partnership and … and investor confidence.
CEO of Bayer AG Anderson on his part commended …
-
"In the Weeds" Glyphosate News Roundup: October 21, 2025
21 Oct 2025 08:13 GMT
… QT, and very hush hush. Bayer AG wants no one to know …
-
JPMorgan Says Correction Will Be “Healthy” – 5 Safe High-Yield Dividend Stocks
21 Oct 2025 00:33 GMT
… with AstraZeneca PLC (NYSE: AZN), Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics …
-
Exelixis plans NDA for zanzalintinib on colorectal cancer data
20 Oct 2025 23:02 GMT
… by 20% vs. Stivarga (regorafenib, Bayer AG) in patients with previously treated …